Package 50268-722-15

{"route": ["ORAL"], "spl_id": "47fc05ed-b529-4ae7-e063-6394a90ae1dd", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["e92350e8-5b0b-95d3-e053-2995a90a959b"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 BOX (50268-722-15)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (50268-722-11)", "package_ndc": "50268-722-15", "marketing_start_date": "20220920"}], "brand_name": "Ranolazine", "product_id": "50268-722_47fc05ed-b529-4ae7-e063-6394a90ae1dd", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "50268-722", "generic_name": "Ranolazine", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA209953", "marketing_category": "ANDA", "marketing_start_date": "20220920", "listing_expiration_date": "20271231"}